세계 유전자 편집 치료(Gene Editing Therapy) 시장을 조사했으며, 시장 개요, 시장 영향요인 및 시장 기회 분석, 신기술 및 기술 개발 동향, 파이프라인 분석, 시장 규모 추이 및 예측, 각종 부문별/지역별 상세 분석, 경쟁 구도, 주요 기업 프로파일 등의 정보를 정리하여 전해드립니다.
목차
제1장 주요 요약
시장 전망
조사 범위
시장 개요
제2장 시장 개요
유전자 편집 툴의 유형
Meganucleases
Zinc Finger Nucleases
Transcription Activator-like Effector Nucleases
Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR)/CRISPR-Associated Protein
Gene editing Therapeutics
제3장 시장 역학
시장 역학 현황
시장 성장 촉진요인
시장 성장 억제요인
시장이 해결해야 할 과제
제4장 신기술과 개발
기반 편집
프라임 편집
Cas-Clover와 Cas-FOKl
CRISPR 간섭과 CRISPR 활성화
RNA 편집
유전자 편집 AI
제5장 파이프라인 분석
개요
임상시험 분석 : 기술별
임상시험 분석 : 질환별
파이프라인 의약품 지정
제6장 특허 분석
제7장 시장 분석
Casgevy
시장 개요
시장 분석
지역별 시장
북미
유럽
신흥 시장
제8장 경쟁 정보
전략적 이니셔티브
경쟁 구도
제9장 유전자 편집 치료 시장 지속가능성 : 환경·사회·거버넌스(ESG) 관점
유전자 편집 기업의 ESG 실천
BCC의 결론
제10장 부록
조사 방법
출전
두자어
기업 개요
ALLOGENE THERAPEUTICS
BEAM THERAPEUTICS
CARIBOU BIOSCIENCES INC.
CRISPR THERAPEUTICS
EDITAS MEDICINE
INTELLIA THERAPEUTICS INC.
PRECISION BIOSCIENCES
SANGAMO THERAPEUTICS
VERTEX PHARMACEUTICALS INC.
VERVE THERAPEUTICS INC.
VOR BIO
LSH
영문 목차
영문목차
The report provides an overview of current and future market potential of gene editing therapeutics and provides a detailed analysis of the drivers, restraints and opportunities in this market. It also include company profiles of key players, featuring detailed information regarding each company’s business segments, financials, product portfolios and recent developments.
Report Scope:
This report highlights the current and future market potential of gene editing therapeutics and provides a detailed analysis of the drivers, restraints and opportunities in this market. It also surveys the competitive environment, including coverage of the pipeline activities adopted by market players, and it includes market projections for 2029. Also included are company profiles of key players, featuring detailed information regarding each company's business segments, financials, product portfolios and recent developments.
Report Includes:
15 data tables and 42 additional tables
An analysis of the current and future global markets for gene editing therapeutics
Analyses of global market trends, with market revenue data (sales figures) for 2021-2023, estimates for 2024, and projected CAGRs through 2029
Estimates of the market size and revenue forecasts for the global gene editing therapeutics market, with market share analysis by region
Discussion of the market dynamics, opportunities, and challenges, as well as emerging technologies
Overview of sustainability trends and ESG developments in the industry, with emphasis on the ESG practices of leading companies, their ESG rankings, and consumer attitudes
Competitive intelligence, including companies' market shares, recent M&A activity, and venture funding
Company profiles of major players within the industry, including CRISPR Therapeutics, Vertex Pharmaceuticals, and Intellia Therapeutics
Table of Contents
Chapter 1 Executive Summary
Market Outlook
Scope of Report
Market Summary
Chapter 2 Market Overview
Introduction
Genome-Editing Tool Types
Meganucleases
Zinc Finger Nucleases
Transcription Activator-like Effector Nucleases
Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR)/CRISPR-Associated Protein 9
Gene editing Therapeutics
Chapter 3 Market Dynamics
Market Dynamics Snapshot
Market Drivers
Increasing Prevalence of Chronic Disease
Increasing Prevalence of Rare Genetic Disorders
Precision Medicine
Increasing Strategic Initiatives
Market Restraints
Stringent Regulatory Frameworks and Time-Consuming Approval Processes
High Cost of Treatment
Adverse Events and Long-Term Monitoring
Lack of Skilled Workforce
Off-Target Impact
Market Challenges
Patent Disputes
Governmental Policies and Regulations
Ethical Issues
Market Opportunities
Chapter 4 Emerging Technologies and Developments
Introduction
Base Editing
Prime Editing
Cas-Clover and Cas-FOKl
CRISPR Interference and CRISPR Activation
RNA Editing
Artificial Intelligence in Genome Editing
Chapter 5 Pipeline Analysis
Overview
Clinical Trial Analysis Based on Technology
Clinical Trial Analysis Based on Diseases
Designations for Pipeline Drugs
Chapter 6 Patent Analysis
Chapter 7 Market Analysis
Introduction
Casgevy
Market Overview
Market Analysis
Market by Region
North America
Europe
Emerging Markets
Chapter 8 Competitive Intelligence
Strategic Initiatives
Competitive Landscape
Chapter 9 Sustainability in the Gene Editing Therapeutics Market: Environmental, Social and Governance (ESG) Perspectives
